Citius Oncology signs exclusive European distribution deal with Uniphar Feb 11, 2026 08:02AM
Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval Dec 23, 2025 04:31PM
Citius Oncology partners with Er-Kim for LYMPHIR distribution in Turkey, GCC Dec 4, 2025 08:37AM
Citius Oncology launches LYMPHIR cancer treatment nationwide Dec 1, 2025 12:08PM
Citius Oncology partners with Verix AI for LYMPHIR launch Nov 21, 2025 08:38AM


Oct 20, 2025 08:38AM Citius Oncology signs distribution deal with McKesson for LYMPHIR launch
Oct 16, 2025 08:47AM Citius Oncology partners with EVERSANA for LYMPHIR drug launch
Oct 7, 2025 08:47AM Citius Oncology partners with Integris Pharma for LYMPHIR access in Europe
Sep 2, 2025 08:08AM Citius Oncology (CTOR) Files $200M Mixed Shelf
Aug 22, 2025 08:47AM Citius Oncology deploys AI platform ahead of LYMPHIR launch
Jul 15, 2025 08:32AM Citius Oncology signs distribution deal with Cencora for LYMPHIR
Jul 8, 2025 08:34AM Citius Pharmaceuticals regains Nasdaq compliance
Jun 17, 2025 08:10AM Citius Oncology (CTOR) Anticipates Commercial Launch of LYMPHIR in 2025
Jun 9, 2025 08:57AM Citius Oncology (CTOR) stock soars on distribution deal
Jun 9, 2025 08:38AM Citius (CTOR) enters distribution agreement with Cardinal Health (CAH)
Feb 6, 2025 08:57AM Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Jan 7, 2025 08:08AM Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) Highlight LYMPHIR Commercial Launch Planned for H1 of 2025
Nov 11, 2024 08:45AM Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) Report Prelim Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab and LYMPHIR